Triple-negative breast cancer (TNBC) accounts for 10–15% of cases and is defined by a lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and lack of human epidermal growth factor 2 (HER2) over-expression [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.